Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 15;11(8):e0161136.
doi: 10.1371/journal.pone.0161136. eCollection 2016.

Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography

Affiliations

Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography

Robert Kromer et al. PLoS One. .

Abstract

Purpose: The retina has been found affected in Parkinson's disease (PD). It is unclear if this is due to neurodegeneration of local dopamine-dependent retinal cells, a result of central nervous degeneration including the optic nerve or retinal small vessel disease. This study aimed to detect changes of the retinal vasculature in PD patients compared to controls.

Methods: We examined 49 PD patients and 49 age- and sex-matched healthy controls by spectral domain optical coherence tomography (SD-OCT) with a circular scan centred at the optic disc. Vessels within the retinal nerve fibre layer were identified by an automated algorithm and thereafter manually labelled as artery or vein. Layer segmentation, vessel lumen and direct surrounding tissue were marked automatically with a grey value and the contrast between both values in relation to the surrounding tissue was calculated. The differences in these grey value ratios among subjects were determined and used as an indicator for differences in vessel morphology. Furthermore, the diameters of the veins and arteries were measured and then compared between the groups.

Results: The contrast of retinal veins was significantly lower in PD patients compared to controls, which indicates changes in vessel morphology in PD. The contrast of arteries was not significantly different. Disease duration, disease stage according to Hoehn and Yahr or age did not influence the grey value ratios in PD patients. Vessel diameter in either veins or arteries did not differ between subject groups. The contrast of retinal veins contralateral to the clinically predominant and first affected side was significantly lower compared to the ipsilateral side.

Conclusion: Our data show a potential difference of the retinal vasculature in PD patients compared to controls. Vascular changes in the retina of PD patients might contribute to vision-related complaints in PD.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Schematic illustration of the SD-OCT-based analysis.
The approaching light is reflected and scattered by the vessels. The hypothesis is that the characteristics of the change in contrast resemble the vessel morphology. In this image the simplified calculation of the change in grey value is achieved by comparing the mean grey value of the blue boxes with that of the green box.
Fig 2
Fig 2. SD-OCT-based vessel analysis.
The red line symbolises the detected vessels; the line drops when there is a vessel in the SD-OCT scan. The grey value of the vessel is measured, and depicted as the green box. This is compared to the grey value of the surrounding tissue, represented as blue boxes.
Fig 3
Fig 3. Comparison of the SD-OCT-based vessel analysis between patients with Parkinson’s disease (PD) and healthy control patients.
Using a paired t-test, PD patients had a significantly lower grey value contrast for veins compared to controls (mean of differences = -3.877±4.464; p-value<0.0001). The grey value contrast for arteries was not different between the groups (p-value = 0.2926).
Fig 4
Fig 4. Correlation of the vessel contrast change in patients with PD with parameters of disease progression and age.
(A) Disease duration did not correlate with the vessel contrast (p-value>0.05). (B) The clinical progression chart Hoehn and Yahr did not correlate with the vessel contrast (p-value>0.05). (C) The age of the patients did not correlate with the vessel contrast (p-value>0.05).
Fig 5
Fig 5. Comparison of the vessel contrast change between the dominant and non-dominant side of PD patients.
The grey value vessel ratio for veins was significantly different (p-value = 0.0060), while arteries showed no significant difference (p-value>0.05).

Similar articles

Cited by

References

    1. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol. 2002;249 Suppl 3: III–1–5. - PubMed
    1. Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson's disease. Parkinsonism Relat Disord. 2010;16: 79–84. 10.1016/j.parkreldis.2009.08.007 - DOI - PubMed
    1. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. The retina in Parkinson's disease. Brain. Oxford University Press; 2009;132: 1128–1145. 10.1093/brain/awp068 - DOI - PubMed
    1. Chaudhuri KR, Healy DG, Schapira AHV, National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5: 235–245. 10.1016/S1474-4422(06)70373-8 - DOI - PubMed
    1. Liew G, Wang JJ, Mitchell P, Wong TY. Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging. Lippincott Williams & Wilkins; 2008;1: 156–161. 10.1161/CIRCIMAGING.108.784876 - DOI - PubMed

Grants and funding

The authors have no support or funding to report.